Toggle navigation menu
Home
About
Acorda
Company
Leadership
Management Team
Board of Directors
Partnering
With Acorda
Grant
Program
Scientific
Award
Compliance
Acorda Compliance
Biotie EFPIA Discolsures
Message From
BIO
Diversity and
Inclusion
Contact Us
For
Patients
Focus On
Therapies
In the
Community
Resources
Policy on Access to
Unapproved Medicines
Products &
Research
Pipeline
ARCUS® Technology
Products
AMPYRA®
(dalfampridine)
INBRIJA™
(levodopa inhalation powder)
Clinical
Trials
Terms and Conditions
(Product Purchases)
Investors
Corporate
Governance
Stock
Information
Investor Events
Investor News
Financial
Information
Quarterly Updates
Annual Reports
SEC Filings
Analysts
Investor
Resources
Investor Kit
E-mail Alerts
FAQs
IR Contact
News &
Events
In the News
Awards
Press Releases
Social Media
Careers
Working at
Acorda
Our
Employees
Benefits
Job Openings
Application
Home
About
Acorda
Company
Leadership
Management Team
Board of Directors
Partnering
With Acorda
Grant
Program
Scientific
Award
Compliance
Acorda Compliance
Biotie EFPIA Discolsures
Message From
BIO
Diversity and
Inclusion
Contact Us
For
Patients
Focus On
Therapies
In the
Community
Resources
Policy on Access to
Unapproved Medicines
Products &
Research
Pipeline
ARCUS® Technology
Products
AMPYRA®
(dalfampridine)
INBRIJA™
(levodopa inhalation powder)
Clinical
Trials
Terms and Conditions
(Product Purchases)
Investors
Corporate
Governance
Stock
Information
Investor Events
Investor News
Financial
Information
Quarterly Updates
Annual Reports
SEC Filings
Analysts
Investor
Resources
Investor Kit
E-mail Alerts
FAQs
IR Contact
News &
Events
In the News
Awards
Press Releases
Social Media
Careers
Working at
Acorda
Our
Employees
Benefits
Job Openings
Application
Privacy Policy
Terms Of Use
Site Map
Contact Us
Annual Reports
Files on this page are PDF. Download
Acrobat Reader
free of charge.
Title
Format
2020
Annual Reports
2020 10-K
(PDF
2.65 MB
)
2020 Annual Report
(PDF
2.17 MB
)
2021 Proxy Statement
(PDF
1.18 MB
)
Supplemental Reports
2019
Annual Reports
2019 10-K
(PDF
2.55 MB
)
2019 Annual Report
(PDF
1.13 MB
)
2020 Proxy Statement
(PDF
1.64 MB
)
2020 Special Proxy Statement
(PDF
1.08 MB
)
Supplemental Reports
2018
Annual Reports
2018 10-K
(PDF
2.47 MB
)
2018 Annual Report
(PDF
3.59 MB
)
2018 Online Annual Report
2019 Proxy Statement
(PDF
1.58 MB
)
Supplemental Reports
2017
Annual Reports
2017 10-K
(PDF
2.30 MB
)
2017 Annual Report
(PDF
7.82 MB
)
2017 Online Annual Report
2018 Proxy Statement
(PDF
1.66 MB
)
Supplemental Reports
2016
Annual Reports
2016 10-K
(PDF
1.01 MB
)
2016 Annual Report
(PDF
3.78 MB
)
2016 Online Annual Report
2017 Proxy Statement
(PDF
807 KB
)
Supplemental Reports
2015
Annual Reports
2015 10-K
(PDF
1.09 MB
)
2015 Annual Report
(PDF
1.73 MB
)
2015 Online Annual Report
2016 Proxy Statement
(PDF
623 KB
)
Supplemental Reports
2014
Annual Reports
2014 10-K
(PDF
2.32 MB
)
2014 Annual Report
(PDF
12.41 MB
)
2014 Online Annual Report
2015 Proxy Statement
(PDF
1.24 MB
)
Supplemental Reports
2013
Annual Reports
2013 10-K
(PDF
2.12 MB
)
2013 Annual Report
(PDF
515 KB
)
2013 Annual Report
2013 Proxy Statement
(PDF
1.11 MB
)
Supplemental Reports
2012
Annual Reports
2012 10-K
(PDF
1.08 MB
)
2012 Annual Report
(PDF
814 KB
)
2012 Annual Report
2012 Proxy Statement
(PDF
448 KB
)
Supplemental Reports
2011
Annual Reports
2011 10-K
(PDF
1.03 MB
)
2011 Annual Report
(PDF
559 KB
)
2011 Annual Report
2011 Proxy Statement
(PDF
426 KB
)
Supplemental Reports
2010
Annual Reports
2010 10-K
(PDF
631 KB
)
2010 Annual Report
(PDF
1.84 MB
)
2010 Annual Report
2010 Proxy Statement
(PDF
250 KB
)
Supplemental Reports
2009
Annual Reports
2009 10-K
(PDF
317 KB
)
2009 Annual Report
(PDF
2.06 MB
)
2009 Annual Report
2009 Proxy Statement
(PDF
123 KB
)
Supplemental Reports
2008
Annual Reports
2008 10-K
(PDF
372 KB
)
2008 Annual Report
(PDF
708 KB
)
2008 Annual Report
2008 Proxy Statement
(PDF
119 KB
)
Supplemental Reports
2007
Annual Reports
2007 10-K
(PDF
832 KB
)
2007 Annual Report
(PDF
210 KB
)
2007 Annual Report
Proxy Statement
(PDF
230 KB
)
Supplemental Reports
Quick Links
View our investor kit
MEET OUR LEADERSHIP TEAM
Board Of Directors
Contact Us
Pipeline
SEC Filings
Email Alerts
Un-subscribe from email alerts
Email Address
*
Mailing Lists
*
News Releases Alert
SEC Alert
Events Alert
Calendar Alert
Text size
Normal
Larger
Largest
Print
ABOUT ACORDA
Company Leadership
Management Team
Board of Directors
Partnering With Acorda
Grant Program
Scientific Award
Compliance
Acorda Compliance
Biotie EFPIA Discolsures
Message From BIO
Diversity and Inclusion
Contact Us
FOR PATIENTS
Focus On Therapies
In The Community
Resources
Policy on Access to
Unapproved or
Uncommericalized
Medicines
PRODUCTS & RESEARCH
Pipeline
ARCUS® Technology
Products
AMPYRA®
(dalfampridine)
INBRIJA™
(levodopa inhalation powder)
Terms and Conditions
(Product Purchases)
Clinical Trials
INVESTORS
Corporate Governance
Stock Information
Investors Events
Investor News
Financial Information
Quarterly Reports
Annual Reports
SEC Filings
Analysts
Investor Resources
Investor Kit
E-mail Alerts
FAQs
IR Contact
NEWS & EVENTS
In The News
Awards
Investor News
Social Media
CAREERS
Working At Acorda
Our Employees
Benefits
Job Openings
Application
Home
|
Privacy Policy
|
Terms Of Use
|
Site Map
|
Contact Us
© Copyright 2017
Powered By Q4 Inc.
5.56.0.1